LA. Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites. Clin Chem. 1997 Dec;43(12):2233-43. \[[PubMed: 9439438](https://pubmed.ncbi.nlm.nih.gov/9439438)\] 5. Greene DN, Schmidt RL, Kamer SM, Grenache DG, Hoke C, Lorey TS. Limitations in qualitative point of care hCG tests for detecting early pregnancy. Clin Chim Acta. 2013 Jan 16;415:317-21. \[[PubMed: 23159297](https://pubmed.ncbi.nlm.nih.gov/23159297)\] 6. Braunstein GD. False-positive serum human chorionic gonadotropin results: causes, characteristics, and recognition. Am J Obstet Gynecol. 2002 Jul;187(1):217-24. \[[PubMed: 12114913](https://pubmed.ncbi.nlm.nih.gov/12114913)\] 7. Cole LA, Shahabi S, Butler SA, Mitchell H, Newlands ES, Behrman HR, Verrill HL. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases. Clin Chem. 2001 Feb;47(2):308-15. \[[PubMed: 11159780](https://pubmed.ncbi.nlm.nih.gov/11159780)\] 8. Marcillac I, Troalen F, Bidart JM, Ghillani P, Ribrag V, Escudier B, Malassagne B, Droz JP, Lhomm√© C, Rougier P. Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms. Cancer Res. 1992 Jul 15;52(14):3901-7. \[[PubMed: 1377600](https://pubmed.ncbi.nlm.nih.gov/1377600)\] 9. Alfthan H, Haglund C, Roberts P, Stenman UH. Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res. 1992 Sep 01;52(17):4628-33. \[[PubMed: 1324787](https://pubmed.ncbi.nlm.nih.gov/1324787)\] 10. Sheaff MT, Martin JE, Badenoch DF, Baithun SI. beta hCG as a prognostic marker in adenocarcinoma of the prostate. J Clin Pathol. 1996 Apr;49(4):329-32. \[[PMC free article: PMC500461](/pmc/articles/PMC500461/)\] \[[PubMed: 8655711](https://pubmed.ncbi.nlm.nih.gov/8655711)\] 11. Lundin M, Nordling S, Carpelan-Holmstrom M, Louhimo J, Alfthan H, Stenman UH, Haglund C. A comparison of serum and tissue hCG beta as prognostic markers in colorectal cancer. Anticancer Res. 2000 Nov-Dec;20(6D):4949-51. \[[PubMed: 11326644](https://pubmed.ncbi.nlm.nih.gov/11326644)\] 12. Reisenbichler ES, Krontiras H, Hameed O. Beta-human chorionic gonadotropin production associated with phyllodes tumor of the breast: an unusual paraneoplastic phenomenon. Breast J. 2009 Sep-Oct;15(5):527-30. \[[PubMed: 19624411](https://pubmed.ncbi.nlm.nih.gov/19624411)\] 13. Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem. 1999 Jul;45(7):942-56. \[[PubMed: 10388468](https://pubmed.ncbi.nlm.nih.gov/10388468)\] 14. Check JH, Nowroozi K, Chase JS, Lauer C, Elkins B, Wu CH. False-positive human chorionic gonadotropin levels caused by a heterophile antibody with the immunoradiometric assay. Am J Obstet Gynecol. 1988 Jan;158(1):99-100. \[[PubMed: 2447778](https://pubmed.ncbi.nlm.nih.gov/2447778)\] 15. Knight AK, Bingemann T, Cole L, Cunningham-Rundles C. Frequent false positive beta human chorionic gonadotropin tests in immunoglobulin A deficiency. Clin Exp Immunol. 2005 Aug;141(2):333-7. \[[PMC free article: PMC1809437](/pmc/articles/PMC1809437/)\] \[[PubMed: 15996198](https://pubmed.ncbi.nlm.nih.gov/15996198)\] 16. Fahy BG, Gouzd VA, Atallah JN. Pregnancy tests with end-stage renal disease. J Clin Anesth. 2008 Dec;20(8):609-13. \[[PubMed: 19100935](https://pubmed.ncbi.nlm.nih.gov/19100935)\] 17. Delbeke FT, Van Eenoo P, De Backer P. Detection of